high rates of fungal transmission. They looked for, and found, reservoirs of infection by analysing the forest soil for DNA traces of Bsal. The fungus might therefore be able to survive and remain infectious for long periods outside its host. This hypothesis was confirmed when the authors observed that an uninfected salamander could be infected by contact with soil that an infected fire salamander had contaminated. Contamination probably occurred through the shedding of fungal spores.
Notably, the authors demonstrated that environmental persistence was explained by the presence of a previously unknown type of resilient and non-motile thick-walled Bsal spore, which has unique characteristics that promote its survival. These fungal spores, known as encysted spores, are protected by a thick, water-repellent cell wall. They can float at the interface between air and water, rather than having the active swimming behaviour found in another type of Bsal spore, known as a motile zoospore. The Bsal encysted spores probably help extend the infectious lifetime of the fungus, because encysted spores had a substantially higher survival rate than the motile zoospores when exposed to microscopic pond predators known as zooplankton. The authors tested whether encysted spores could adhere to the feet of waterfowl and found that they could. This might mean that birds disperse Bsal into previously uninfected and distant populations, perhaps explaining the extraordinarily rapid spread of the infection (Fig. 1) .
Stegen et al. also searched for non-salamander reservoirs of infection that could be intensifying the outbreak. Previous experiments 6 suggested that the Bsal host range was limited to newt and salamander species. Stegen and colleagues found that the frog species Alytes obstetricans (the common midwife toad) could be infected by the fungus and transmit the disease to salamanders. Infection of the alpine newt Ichthyosaura alpestris, which shares the forests with the salamanders alongside A. obstetricans, revealed that the newts could develop chronic Bsal infections. These newts showed little evidence of acquiring protective immunity against pathogen re-infection, which indicates that they too are natural reservoirs for this pathogen.
As Stegen and colleagues mention, the combination of multiple susceptible hosts and a virulent and environmentally persistent pathogen seems to create a 'perfect storm' of infection that has led to the almost complete destruction of fire salamanders in the populations infected so far. Their observations are consistent with a model of Bsal dynamics in which infectious spores build up in multiple reservoirs across the timescale of an outbreak, creating a highly infected ecosystem. More must be done to try to conserve fire salamanders and other susceptible amphibian species that have restricted ranges and are under direct threat of extinction from Bsal. It should also become a priority to try to prevent introductions of other nonnative pathogenic chytrids because, despite decades of research, no effective method has emerged to reduce their effect in the field 10 . It is currently unclear how Bsal can be combated in the wild beyond establishing 'amphibian arks' to safeguard susceptible species as the infection marches relentlessly onwards. Clearly, scientists, policymakers and citizens have much to do if we are to help Europe's salamanders weather this perfect storm. ■
Matthew C. Fisher is in the Department of Infectious Disease Epidemiology, Imperial
College London, London W2 1PG, UK. e-mail: matthew.fisher@imperial.ac.uk
A bout ten years ago, atomically thin layers of carbon atoms known as graphene sheets were shown to be highly transparent to visible light, making graphene a promising material for electronic display applications 1, 2 . Then, in 2012, the phenomenon of liquid wetting on solid surfaces was, in some instances, found to be unaffected by an interposed sheet of graphene -the ultrathin sheet is 'transparent' to wetting, so that the arrangement of water molecules in a droplet is driven by interactions with the substrate that lies beneath the graphene 3 . On page 340, Kim et al. 4 ask whether crystal growth can take place through a sheet of graphene, and report that the answer is yes: atoms of gallium and arsenic 'see through' a graphene layer to an underlying gallium arsenide (GaAs) crystal, and thus adopt an arrangement that seamlessly continues the lattice structure of the substrate.
The process in which materials are grown over the top of a substrate is known as epitaxy. Epitaxial growth of GaAs and related compounds lies at the heart of a wide range of modern technologies, including light-emitting diodes for energy-efficient solid-state lighting 5 , lasers for optical telecommunication 6 , and high-speed circuits for mobile phones and other wireless communication 7 . In ordinary processes for growing GaAs using epitaxy, great pains are taken to ensure that the substrate's surface is free from contamination by other materials or by GaAs oxide.
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Crystals aligned through graphene
Graphene has been used as a 'transparent' layer that allows single crystals of a material to be grown on a substrate, and then lifted off -in much the same way that baking paper lets cakes be removed easily from tins. See Letter p.340 This is because the gallium and arsenic atoms supplied to the surface need to be able to 'feel' the atomic arrangement of the GaAs substrate. Placing a layer of graphene on top of such a carefully prepared surface might therefore be expected to interfere with the ability of the substrate to guide the process of epitaxial growth. This is where the atomic thinness of graphene comes into play. Using first-principles computations, Kim et al. showed that a graphene interlayer should not prevent newly arriving gallium and arsenic atoms from interacting with the GaAs substrate beneath, provided that the interlayer is less than 9 ångströms thick. The authors then used metal-organic vapour-phase epitaxy, a commonly used industrial technique, to show that smooth, single crystals of GaAs at the squaremillimetre scale can grow epitaxially on a graphene-coated GaAs substrate -a process they call remote epitaxy (Fig. 1) .
Kim et al. went on to use a wide range of diffraction and electron-microscopy techniques, from the atomic to the millimetre scale, to prove that the observed growth was indeed directed by the GaAs substrate. To underscore the point, the authors repeated the experiment using GaAs substrates covered with two and four layers of graphene, and observed only rough, disordered polycrystalline growth. The substrate can no longer guide the arrangement of gallium and arsenic atoms through such thick barriers -the multi-layer graphene is 'opaque' to epitaxy.
So does this fundamental investigation of crystal growth have technological applications? To address this question, Kim et al. showed that a single layer of graphene enables GaAs films to bond strongly enough with the substrate to allow epitaxy, and yet weakly enough to allow film removal (exfoliation) under mechanical stress. This enabled the authors to grow visible-light-emitting diodes (roughly 0.1-to 1.0-micrometres thick) on graphene-GaAs and then exfoliate them. The devices retained their functionality after being transferred to a silicon carrier. Such thin devices can be highly bendable when separated from their brittle substrates, creating opportunities for flexible electronics 8 . The exfoliation enabled by the graphene interlayer differs from typical methods 9, 10 , which require the chemical etching of a sacrificial layer and/or mechanical polishing of the substrate to afford a smooth surface for subsequent epitaxial growth. It is also worth noting that the graphene-coated GaAs substrates can be reused for epitaxy. Given that substrates of GaAs and other semiconductors can be expensive, the ability to reuse substrates could create substantial cost savings in applications that involve large areas, such as high-efficiency solar cells.
Some hurdles remain before Kim and colleagues' epitaxial process is ready for commercial application. First, although the researchers show that the surfaces of the epitaxially grown GaAs films are smooth on the micrometre scale, they are not uniformly smooth over large areas (square millimetres). Second, any defects present in the graphene interlayer cause damage to the substrate and the film during exfoliation. Moreover, the authors prepared epitaxial templates by transferring previously prepared graphene onto GaAs substrates. A process for directly forming single layers of graphene on GaAs could greatly simplify things, and might allow larger, more uniform GaAs films to be made. Work will also be needed to show that devices with state-of-the-art performance can be made, such as low-threshold lasers or high-efficiency solar cells.
In addition to positioning remote epitaxy as a new mode of crystal growth, Kim and colleagues' work might open up manufacturing processes for low-cost flexible optoelectronics. The results also raise important fundamental questions, such as how dislocations, stacking faults and other crystal defects in 3D materials might interact with 2D materials. And would other 2D materials, such as boron nitride, be similarly transparent to epitaxy? Finally, the work might inspire research into devices that marry the distinctive characteristics of 2D materials -such as their electronic, optical, and thermal properties -with the ultra-high performance, exquisite control and structural perfection that can be achieved using 3D epitaxial semiconductors. ■ 
Minjoo Larry Lee is in the Department
Two-for-one on potential therapies
Molecules that inhibit the synthesis of the ataxin 2 protein can ameliorate the effects of two neurodegenerative diseases in mouse models, raising hopes for the success of this approach in clinical trials. See Letters p.362 & p.367
eurodegenerative disorders can be devastating, and many lack effective treatments. One possible therapeutic strategy involves the use of antisense oligo nucleotides (ASOs) -short stretches of nucleotides that bind to a messenger RNA and inhibit its translation into protein. Support for this idea is provided by two papers in this issue 1, 2 , which report that ASOs that target mRNA translated into the ataxin 2 protein can ameliorate movement defects in mouse models of neurodegenerative disease.
In the first study, Scoles et al. 1 (p. 362) investigated the use of ASOs to tackle a disease called spinocerebellar ataxia type 2, in which mutations in ataxin 2 cause neurodegeneration. This leads to neuronal abnormalities, including decreases in the firing of neurons called Purkinje cells in the brain's cerebellum, and to motor defects, which affect movement 3 (Fig. 1a) . The authors began by screening 152 ASOs in vitro, to identify those that reduced cellular levels of ataxin 2 mRNA most efficiently.
Next, they injected this molecule into two different mouse models of spinocerebellar ataxia type 2, both of which had been genetically engineered to express a mutated form of human ataxin 2. The mutant mice exhibit deterioration in movement during adulthood, mimicking the human disease. However, ASO injection into the animals' brain and cerebrospinal fluid lowered the levels of ataxin 2 protein in these regions. As a result, the decline of the creatures' motor performance was significantly slowed compared with untreated controls.
Scoles and colleagues went on to investigate the molecular mechanisms underlying this improvement. They found that abnormal
